Skip to main content
. 2017 Sep 22;8(50):88179–88188. doi: 10.18632/oncotarget.21165

Table 1. Pooled analyses of the association between NLRP1 polymorphisms and susceptibility to vitiligo.

SNP Models M I2 Pheterogeneity Stratification case/control (N) OR [95% CI] Passociation
rs12150220 T vs. A Fixed 33.5% 0.222 overall/ Asian 563/1,351 (3) 1.17 [1.00~1.38] 0.057
TT vs. AA Fixed 0.0% 0.470 overall/ Asian 563/1,351 (3) 1.55 [0.77~1.72] 0.492
AT vs. AA Fixed 0.0% 0.896 overall/ Asian 563/1,351 (3) 1.32 [1.07~1.64] 0.011
AT+TT vs. AA Fixed 0.0% 0.861 overall/ Asian 563/1,351 (3) 1.29 [1.05~1.59] 0.014
TT vs. AA+AT Fixed 40.3% 0.187 overall/ Asian 563/1,351 (3) 0.97 [0.66~1.42] 0.866
carrier T vs. A Fixed 0.0% 0.513 overall/ Asian 563/1,351 (3) 1.15 [0.95~1.38] 0.149
rs2670660 G vs. A Random 84.6% < 0.001 overall 719/1,534 (5) 1.26 [0.84~1.90] 0.258
88.2% < 0.001 Asian 653/1,441(4) 1.19 [0.72~1.96] 0.491
88.2% < 0.001 PHWE > 0.05 693/1,473 (4) 1.20 [0.75~1.90] 0.452
GG vs. AA Random 81.7% < 0.001 overall 719/1,534 (5) 1.62 [0.73~3.59] 0.234
85.9% < 0.001 Asian 653/1,441(4) 1.40 [0.53~3.73] 0.500
86.2% < 0.001 PHWE > 0.05 693/1,473 (4) 1.47 [0.58~3.71] 0.414
AG vs. AA Random 76.3% 0.002 overall 719/1,534 (5) 1.49 [0.88~2.53] 0.142
78.6% 0.003 Asian 653/1,441 (4) 1.30 [0.73~2.32] 0.368
80.7% 0.001 PHWE > 0.05 693/1,473 (4) 1.37 [0.77~2.43] 0.289
AG+GG vs. AA Random 84.2% < 0.001 overall 719/1,534 (5) 1.53 [0.84~2.81] 0.165
86.9% < 0.001 Asian 653/1,441 (4) 1.35 [0.68~2.66] 0.395
87.6% < 0.001 PHWE > 0.05 693/1,473 (4) 1.40 [0.72~2.74] 0.327
GG vs. AA+AG Random 64.4% 0.024 overall 719/1,534 (5) 1.25 [0.77~2.01] 0.370
72.9% 0.011 Asian 653/1,441(4) 1.20 [0.64~2.24] 0.573
73.2% 0.011 PHWE > 0.05 693/1,473 (4) 1.21 [0.68~2.13] 0.513
carrier G vs. A Random 56.5% 0.056 overall 719/1,534 (5) 1.18 [0.89~1.56] 0.262
66.9% 0.028 Asian 653/1,441(4) 1.13 [0.80~1.61] 0.481
66.8% 0.029 PHWE > 0.05 693/1,473 (4) 1.14 [0.83~1.58] 0.420
rs6502867 C vs. T Random 80.5% < 0.001 overall 719/1,534 (5) 1.06 [0.70~1.61] 0.768
64.7% 0.037 Asian 653/1,441(4) 1.29 [0.93~1.80] 0.130
85.1% < 0.001 PHWE > 0.05 693/1,473 (4) 1.05 [0.65~1.70] 0.831
CC vs. TT Random 65.3% 0.021 overall 719/1,534 (5) 1.30 [0.62~2.72] 0.490
52.1% 0.099 Asian 653/1,441(4) 1.73 [0.92~3.26] 0.397
71.0% 0.016 PHWE > 0.05 693/1,473 (4) 1.40 [0.64~3.07] 0.397
TC vs. TT Random 73.6% 0.004 overall 719/1,534 (5) 1.04 [0.64~1.69] 0.873
55.7% 0.080 Asian 653/1,441(4) 1.27 [0.85~1.90] 0.238
79.9% 0.002 PHWE > 0.05 693/1,473 (4) 0.96 [0.55~1.69] 0.901
TC+CC vs. TT Random 80.1% < 0.001 overall 719/1,534 (5) 1.07 [0.63~1.81] 0.805
65.7% 0.033 Asian 653/1,441(4) 1.34 [0.87~2.07] 0.186
85.1% < 0.001 PHWE > 0.05 693/1,473 (4) 1.01 [0.55~1.87] 0.963
CC vs. TT+TC Fixed 37.7% 0.170 overall 719/1,534 (5) 1.59 [1.21~2.09] 0.001
15.1% 0.316 Asian 653/1,441(4) 1.69 [1.27~2.24] < 0.001
41.1% 0.165 PHWE > 0.05 693/1,473 (4) 1.63 [1.24~2.16] 0.001
carrier C vs. T Random 54.7% 0.065 overall 719/1,534 (5) 1.07 [0.79~1.46] 0.653
10.8% 0.339 Asian 653/1,441(4) 1.26 [1.04~1.53] 0.021
65.9% 0.032 PHWE > 0.05 693/1,473 (4) 1.05 [0.79~1.46] 0.782

SNP, Single Nucleotide Polymorphism; HWE, Hardy-Weinberg equilibrium; Pheterogeneity, P value of Cochrane's Q statistic for the assessment of heterogeneity; M, statistical model; OR, odds ratio; CI, confidence interval; Passociation, P value of association test;

N, Number of included case-control studies.